Price gouging in the specialty drug market is driving the cost of vital drugs up to $750 to $1,000 a tablet. The Spokesman-Review’s article nails the issue right on the head: “Patients are placed at a significant disadvantage by a health care market that lacks clear pricing, and often are denied the opportunity to choose more affordable options. The result is a medical marketplace that allows hospitals and drugmakers to routinely take advantage of people.” Aimed Alliance believes in price transparency and affordable access to treatment for everyone. Read the full story here.
Last Updated on May 7, 2020 by Aimed Alliance
